Cargando…
The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites
BACKGROUND: Malaria remains a disease of devastating global impact, killing more than 800,000 people every year—the vast majority being children under the age of 5. While effective therapies are available, if malaria is to be eradicated a broader range of small molecule therapeutics that are able to...
Autores principales: | Delves, Michael, Plouffe, David, Scheurer, Christian, Meister, Stephan, Wittlin, Sergio, Winzeler, Elizabeth A., Sinden, Robert E., Leroy, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283556/ https://www.ncbi.nlm.nih.gov/pubmed/22363211 http://dx.doi.org/10.1371/journal.pmed.1001169 |
Ejemplares similares
-
The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro
por: Walz, Annabelle, et al.
Publicado: (2023) -
Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites
por: Dorjsuren, Dorjbal, et al.
Publicado: (2021) -
Fueling Open Innovation for Malaria Transmission-Blocking Drugs: Hundreds of Molecules Targeting Early Parasite Mosquito Stages
por: Delves, Michael, et al.
Publicado: (2019) -
In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models
por: Schleiferböck, Sarah, et al.
Publicado: (2013) -
Targeting the parasite in the mosquito: rationale and practicality
por: Sinden, Robert E, et al.
Publicado: (2012)